vs

Side-by-side financial comparison of Canopy Growth Corp (CGC) and HARTE HANKS INC (HHS). Click either name above to swap in a different company.

Canopy Growth Corp is the larger business by last-quarter revenue ($54.4M vs $39.9M, roughly 1.4× HARTE HANKS INC). HARTE HANKS INC runs the higher net margin — 5.5% vs -84.0%, a 89.5% gap on every dollar of revenue. On growth, Canopy Growth Corp posted the faster year-over-year revenue change (-0.3% vs -15.4%). Over the past eight quarters, Canopy Growth Corp's revenue compounded faster (1.2% CAGR vs -6.4%).

Canopy Growth Corporation, formerly Tweed Marijuana Inc., is a cannabis company based in Smiths Falls, Ontario.

Harte Hanks is a global marketing services company headquartered in Boston, Massachusetts. Harte Hanks services include analytics, strategy, marketing technology, creative services, digital marketing, customer care, direct mail, logistics, and fulfillment.

CGC vs HHS — Head-to-Head

Bigger by revenue
CGC
CGC
1.4× larger
CGC
$54.4M
$39.9M
HHS
Growing faster (revenue YoY)
CGC
CGC
+15.1% gap
CGC
-0.3%
-15.4%
HHS
Higher net margin
HHS
HHS
89.5% more per $
HHS
5.5%
-84.0%
CGC
Faster 2-yr revenue CAGR
CGC
CGC
Annualised
CGC
1.2%
-6.4%
HHS

Income Statement — Q3 FY2026 vs Q4 FY2025

Metric
CGC
CGC
HHS
HHS
Revenue
$54.4M
$39.9M
Net Profit
$-45.7M
$2.2M
Gross Margin
28.8%
Operating Margin
-35.3%
-0.3%
Net Margin
-84.0%
5.5%
Revenue YoY
-0.3%
-15.4%
Net Profit YoY
48.6%
EPS (diluted)
$0.30

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CGC
CGC
HHS
HHS
Q4 25
$54.4M
$39.9M
Q3 25
$48.7M
$39.5M
Q2 25
$52.7M
$38.6M
Q1 25
$47.5M
$41.6M
Q4 24
$54.6M
$47.1M
Q3 24
$46.0M
$47.6M
Q2 24
$48.3M
$45.0M
Q1 24
$53.1M
$45.4M
Net Profit
CGC
CGC
HHS
HHS
Q4 25
$-45.7M
$2.2M
Q3 25
$-1.2M
$-2.3M
Q2 25
$-30.3M
$-335.0K
Q1 25
$-392.0K
Q4 24
$-89.0M
Q3 24
$-93.7M
$142.0K
Q2 24
$-92.8M
$-27.8M
Q1 24
$-171.0K
Gross Margin
CGC
CGC
HHS
HHS
Q4 25
28.8%
Q3 25
32.8%
Q2 25
25.0%
Q1 25
16.2%
Q4 24
32.2%
Q3 24
34.7%
Q2 24
34.8%
Q1 24
21.3%
Operating Margin
CGC
CGC
HHS
HHS
Q4 25
-35.3%
-0.3%
Q3 25
-25.3%
1.3%
Q2 25
-31.4%
0.1%
Q1 25
-0.1%
Q4 24
-31.9%
-3.3%
Q3 24
-72.9%
4.0%
Q2 24
-44.0%
3.0%
Q1 24
0.8%
Net Margin
CGC
CGC
HHS
HHS
Q4 25
-84.0%
5.5%
Q3 25
-2.5%
-5.8%
Q2 25
-57.6%
-0.9%
Q1 25
-0.9%
Q4 24
-163.0%
Q3 24
-203.7%
0.3%
Q2 24
-192.0%
-61.8%
Q1 24
-0.4%
EPS (diluted)
CGC
CGC
HHS
HHS
Q4 25
$0.30
Q3 25
$-0.31
Q2 25
$-0.05
Q1 25
$-0.05
Q4 24
$-0.31
Q3 24
$0.02
Q2 24
$-3.84
Q1 24
$-0.02

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CGC
CGC
HHS
HHS
Cash + ST InvestmentsLiquidity on hand
$271.1M
$5.6M
Total DebtLower is stronger
Stockholders' EquityBook value
$553.5M
$20.5M
Total Assets
$807.5M
$91.8M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CGC
CGC
HHS
HHS
Q4 25
$271.1M
$5.6M
Q3 25
$217.6M
$6.5M
Q2 25
$104.8M
$4.8M
Q1 25
$96.0M
$9.0M
Q4 24
$130.2M
$9.8M
Q3 24
$168.8M
$5.9M
Q2 24
$142.3M
$11.0M
Q1 24
$148.5M
$11.5M
Stockholders' Equity
CGC
CGC
HHS
HHS
Q4 25
$553.5M
$20.5M
Q3 25
$537.3M
$19.9M
Q2 25
$357.0M
$22.2M
Q1 25
$355.7M
$21.4M
Q4 24
$431.8M
$21.7M
Q3 24
$372.1M
$21.0M
Q2 24
$389.0M
$20.6M
Q1 24
$365.3M
$20.0M
Total Assets
CGC
CGC
HHS
HHS
Q4 25
$807.5M
$91.8M
Q3 25
$781.0M
$92.7M
Q2 25
$660.4M
$95.0M
Q1 25
$669.9M
$100.6M
Q4 24
$849.9M
$101.8M
Q3 24
$899.6M
$108.1M
Q2 24
$938.9M
$109.7M
Q1 24
$949.2M
$113.4M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CGC
CGC
HHS
HHS
Operating Cash FlowLast quarter
$737.0K
Free Cash FlowOCF − Capex
$-686.0K
FCF MarginFCF / Revenue
-1.7%
Capex IntensityCapex / Revenue
3.6%
Cash ConversionOCF / Net Profit
0.33×
TTM Free Cash FlowTrailing 4 quarters
$-4.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CGC
CGC
HHS
HHS
Q4 25
$737.0K
Q3 25
$3.2M
Q2 25
$-7.5M
$-4.8M
Q1 25
$-121.0M
$-818.0K
Q4 24
$4.0M
Q3 24
$-2.9M
Q2 24
$-37.8M
$1.6M
Q1 24
$-205.8M
$-5.7M
Free Cash Flow
CGC
CGC
HHS
HHS
Q4 25
$-686.0K
Q3 25
$2.2M
Q2 25
$-8.5M
$-5.1M
Q1 25
$-128.9M
$-923.0K
Q4 24
$3.4M
Q3 24
$-4.9M
Q2 24
$-40.7M
$926.0K
Q1 24
$-208.3M
$-6.2M
FCF Margin
CGC
CGC
HHS
HHS
Q4 25
-1.7%
Q3 25
5.5%
Q2 25
-16.1%
-13.1%
Q1 25
-271.5%
-2.2%
Q4 24
7.3%
Q3 24
-10.2%
Q2 24
-84.1%
2.1%
Q1 24
-392.1%
-13.7%
Capex Intensity
CGC
CGC
HHS
HHS
Q4 25
3.6%
Q3 25
2.5%
Q2 25
1.8%
0.6%
Q1 25
16.6%
0.3%
Q4 24
1.3%
Q3 24
4.0%
Q2 24
5.9%
1.5%
Q1 24
4.7%
1.2%
Cash Conversion
CGC
CGC
HHS
HHS
Q4 25
0.33×
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
-20.76×
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CGC
CGC

Other$24.0M44%
Canadian Adult Use Cannabis$22.9M42%
International Markets Cannabis$6.2M11%
Other Geographical Area$1.2M2%

HHS
HHS

Fulfillment And Logistics Services$17.3M43%
Customer Care$13.7M34%
Other$8.9M22%

Related Comparisons